
Chinese pharmaceutical services company. Operates 20+ solid-phase peptide synthesis lines. Passed 2025 FDA inspection with zero observations. Provides peptide API and custom synthesis services with established global export logistics.
Claim this listing to update your information, respond to buyer inquiries, and get a verified badge.
Free to claim. Verified upgrades available.